SUBSCRIBE
SUBSCRIBE

Phase I

Drug Development
Pfizer Head of R&D Talks Strategy on How Pharma Chooses Compounds to Bet A Billion Dollars On
June 16, 2016
 · 
2 min read
Drug Development
ASCO2016: What’s Next For Cancer-Killing T-Cells After Strong ASCO Showings
June 8, 2016
 · 
1 min read
Drug Development
Why Cancer Patients And Doctors Should Rethink The Value Of Phase I Trials
June 3, 2016
 · 
1 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Eli Lilly Projects 20 New Product Launches in 10 Years with 20 Possible Expansions
May 24, 2016
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
13 Massachusetts Cancer Biotechs Looking to Shake Things Up at ASCO in June
May 20, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
From 20 to 84 Employees in Just Four Years, Booming Blueprint Medicines Maps Out a Plan
April 25, 2016
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
Juno, Five Prime are Quiet Winners at AACR
April 21, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Bay Area’s GigaGen Develops Synthetic Immune System to Harness Antibodies
April 19, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Booming Seres Therapeutics Looks to Move Lead Product into Phase III, Expand in Cambridge
April 14, 2016
 · 
4 min read
Alnylam Stock Craters After Deaths Cause Clinical Trial to End
Drug Development
Alnylam’s John Maraganore Provides Leadership for RNAi Development and Biotech Industry
April 1, 2016
 · 
7 min read
Load More
PRESS RELEASES
Drug Development
FDA Removes Partial Clinical Hold on Salarius Pharmaceuticals’ Phase 1/2 Clinical Trial with Seclidemstat in Patients with Ewing Sarcoma
May 9, 2023
 · 
10 min read
Drug Development
Cybin Announces Last Subject Dosed in Part B of its Phase 1 CYB004-E Trial
May 9, 2023
 · 
8 min read
Drug Development
Seres Therapeutics Reports SER-155 Phase 1b Cohort 1 Results Showing Successful Drug Bacteria Engraftment and Substantial Reduction in Pathogen Domination in the Gastrointestinal Microbiome
May 9, 2023
 · 
11 min read
Drug Development
HOOKIPA Announces First Person Dosed in Phase 1a/b Clinical Trial of HB-400, in Collaboration with Gilead, for Treatment of Hepatitis B
May 9, 2023
 · 
5 min read
Drug Development
FibroGen Enters into Exclusive License for FOR46 with Fortis Therapeutics
May 8, 2023
 · 
5 min read
Drug Development
Celcuity to Present Updated Results for Treatment-Naïve Patients from Phase 1b Study of Gedatolisib at the 2023 ESMO Breast Cancer Annual Congress
May 8, 2023
 · 
4 min read
Drug Development
New Data from Phase 1/2 Trial of INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis Presented at ABEA during COSM 2023
May 8, 2023
 · 
8 min read
Business
CureVac Announces Dosing of First Participant in Combined Phase 1/2 Study of Multivalent, Modified Influenza Vaccine Candidates Developed in Collaboration with GSK
May 8, 2023
 · 
5 min read
Drug Development
Seres Therapeutics to Host First Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on May 9, 2023
May 5, 2023
 · 
1 min read
Drug Development
Cocrystal Pharma Presents New Data from its CC-42344 Phase 1 Influenza A Study at the 7th Annual ISIRV Antiviral Group Conference
May 4, 2023
 · 
5 min read
Drug Development
MedinCell: mdc-TJK’s (Teva’s codename: TEV-44749) Phase 1 study pharmacokinetics to be presented for the first time by Teva at SIRS 2023 (May 11-15, 2023, Toronto, Canada)
May 4, 2023
 · 
2 min read
Drug Development
SELLAS Announces Positive Topline Data from GFH009 Phase 1 Dose-Escalation Trial in Acute Myeloid Leukemia Cohort Supporting Advancement to Phase 2 Clinical Study
May 4, 2023
 · 
7 min read
Drug Development
SAB Biotherapeutics Presents Positive Phase 1 and 2a Data for SAB-176 Influenza Immunotherapy at ISIRV-AVG Conference
May 4, 2023
 · 
5 min read
Drug Development
Immunic Reports Positive Results From Phase 1b Clinical Trial of IMU-856 in Celiac Disease, Providing Clinical Proof-of-Concept for New Therapeutic Approach to Gastrointestinal Disorders
May 4, 2023
 · 
13 min read
Drug Development
Trellis Bioscience Announces Positive Interim Phase 1 Results for TRL1068, a Novel Native Human Monoclonal Antibody Which Reduces Bacterial Biofilm Burden in Chronic Prosthetic Joint Infections
May 4, 2023
 · 
7 min read
Drug Development
Endogena Therapeutics Completes Enrollment Ahead of Schedule in its Phase 1/2a Trial of EA-2353 for Retinitis Pigmentosa
May 4, 2023
 · 
3 min read
Drug Development
Zevra Therapeutics Announces FDA Acceptance of IND Application for KP1077 in Narcolepsy
May 3, 2023
 · 
6 min read
Drug Development
Incannex Company Presentation – Results from Phase 1 Clinical Trial to Assess Proprietary IHL-675A
May 3, 2023
 · 
1 min read
Drug Development
EirGenix’s Second Breast Cancer Biosimilar EG1206A Successfully Reaches Phase 1 Clinical Trial Objectives
May 2, 2023
 · 
3 min read
Drug Development
Verismo Therapeutics Announces the Activation of its STAR-101 Clinical Trial at the University of Pennsylvania
May 2, 2023
 · 
3 min read
Load More